Recruiting Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors NCT05269381 Conditions Adenocarcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +165 more Locations Mayo Clinic in Florida — Jacksonville, Florida, United States View Trial Details
Recruiting Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis NCT06794229 Conditions Locally Advanced Renal Cell Carcinoma Locations Washington University School of Medicine — St Louis, Missouri, United States University of Texas Southwestern Medical Center — Dallas, Texas, United States Virginia Commonwealth University — Richmond, Virginia, United States View Trial Details
Completed A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203) NCT03679767 Conditions Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +38 more Locations California Cancer Associates for Research and Excellence, Inc. — Fresno, California, United States California Cancer Associates for Research and Excellence — Fresno, California, United States California Cancer Associates for Research and Excellence, Inc. — San Marcos, California, United States St Joseph Heritage Healthcare — Santa Rosa, California, United States View all 52 locations View more locations Show fewer locations Loading locations... View Trial Details
